| Alyssa Lauren Harris, DMD | |
|
521 4th St, Havre, MT 59501-3649 | |
| (406) 395-4305 | |
| Not Available |
| Full Name | Alyssa Lauren Harris |
|---|---|
| Gender | Female |
| Speciality | Dentist |
| Location | 521 4th St, Havre, Montana |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1568848117 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 122300000X | Dentist | DEN-DEN-LIC-9679 (Montana) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Alyssa Lauren Harris, DMD 521 4th St, Havre, MT 59501-3649 Ph: (406) 395-4305 | Alyssa Lauren Harris, DMD 521 4th St, Havre, MT 59501-3649 Ph: (406) 395-4305 |
News Archive
Australian vaccine development company BioDiem Ltd (ASX: BDM) today announced that it has begun a research collaboration with France-based VIVALIS (Euronext code: VLS), a biopharmaceutical company with expertise in vaccine production technologies.
The American Institute of Biological Sciences (AIBS) is pleased to announce the launch of the 2nd Annual Biological Sciences Congressional District Visits event. This nationwide initiative is intended to spur individual biologists and research centers to meet with their members of Congress during the August congressional district work period.
Amgen today announced the initiation of the ARROW trial, a global Phase 3 study evaluating the benefit of Kyprolis® (carfilzomib) for Injection administered once-weekly with dexamethasone versus the current U.S. Food and Drug Administration (FDA) approved twice-weekly administration schedule in patients with relapsed and refractory multiple myeloma who have received prior treatment with bortezomib and an immunomodulatory agent (IMiD).
An international team of researchers from the University of Zurich, the University Hospital Zurich, Heidelberg and Glasgow has identified a novel function for the cell death regulating protein MCL1: It is essential in protecting the intestine against cancer development – independent of bacterial-driven inflammation.
› Verified 8 days ago
Dr. Gerald Olson, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 424 3rd St, Havre, MT 59501 Phone: 406-265-7886 Fax: 406-265-9782 | |
Ronald Tilgner, DDS Dentist Medicare: Medicare Enrolled Practice Location: 521 4th St, Havre, MT 59501 Phone: 406-395-4305 Fax: 406-395-5643 | |
Robert Andrew Jestrab, DDS Dentist Medicare: Medicare Enrolled Practice Location: 424 3rd St, Havre, MT 59501 Phone: 406-265-7886 | |
Dr. Lee Dennis Laeupple, D.D.S. Dentist Medicare: Not Enrolled in Medicare Practice Location: 35 3rd St, Havre, MT 59501 Phone: 406-265-1790 | |
Lars Monson Swensen, DMD Dentist Medicare: Medicare Enrolled Practice Location: 424 3rd St, Havre, MT 59501 Phone: 406-265-7886 Fax: 406-265-9782 | |
Dr. Michael D Shelby, D.M.D. Dentist Medicare: Not Enrolled in Medicare Practice Location: 130 13th St, Havre, MT 59501 Phone: 406-265-2063 Fax: 406-265-2106 |